XIENCE V Everolimus Eluting Coronary Stent System (EECSS) USA Post-Approval Study
Evaluation of an Investigational Treatment for Chronic Pain
Not Recruiting
18 years - 100 years
All
Phase
N/A
1 Location
Brief description of study.
No Description Available
Detailed description of study
No Description Available
Eligibility of study
You may be eligible for this study if you meet the following criteria:
Conditions:Healthy
Age:
18 years - 100 years
Gender: All
Who can participate: Adults aged 18 to 65 who have been experiencing chronic pain for at least six months and have not responded to standard treatments are eligible to participate.
Study details: Participants will be randomly assigned to receive either the investigational treatment or a placebo. The study will involve regular assessments of pain levels, quality of life, and any side effects.
Updated on
19 Feb 2024.
Study ID: 0807-09
Interested in the study?
Select a study center that’s convenient for you, and get in touch with the study team.
